Contexium

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 02 Nov 2028. This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic and/or dissemination and implementation science clinical trials. Trials using innovative designs such as…

Opportunity overview

Project name
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
National Institutes of Health logo
National Institutes of Health
Donor
National Institutes of Health

Key details

Opportunity start date
Opportunity end date
Project location(s)
United States

Summary

This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct investigator-initiated single site clinical trials including efficacy, comparative...

Frequently asked questions

What is Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)?

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 02 Nov 2028. This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic and/or dissemination and implementation science clinical trials. Trials using innovative designs such as…

Who is funding Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)?

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) is funded by National Institutes of Health.

When is the deadline to apply for Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)?

The application deadline is 02 Nov 2028 00:00 (UTC).

Where will the Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) project take place?

The project location(s) are: United States.

How can I apply for Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.